A bot that flags relevant replications on new preprints (currently running as an RCT).
Get involved: help validate & grow the database — live
validation.forrt.org
Barrier 2
Not foundNot done
The harder problem? It might not have to be.
Why so few get done
Not a motivation problem, an incentive problem.
Novelty is rewarded; verification isn't.
No obvious venue; fears about citations and reputation.
And researchers' own curiosity pulls toward new questions.
Result: <0.1% of articles in top-50 economics journals ; ~1.5% of top-100 psychology articles.
However: who has started an analysis by first checking the original effect still shows up, before testing something new? More than 1.5% of the time? Hold that thought.
The rest of the talk
Two routes to more replication
Route 1: the replication is the contribution
It needs a credible home. → Replication Research (R2)
Route 2: the replication is the foundation for a new question
Makes "normal" science more cumulative. → replicate-and-extend
Route 1 · the problem
"No room at the inn" for replications
The Pottery Barn rule — a journal should publish replications of what it published — has almost no uptake (RSOS the notable exception).
Publication is concentrated: 4 economics journals ≈ ⅓ of econ replications; 6 psychology journals ≈ 60% of direct replications (2010–2021). (Reed et al., 2025)
And staying a preprint roughly halves your citations vs. a journal article.
R2: a home for replications — live
replicationresearch.org
Route 1
A specialised and special journal
Citable, peer-reviewed publication
Review criteria built for replication, not retrofitted from novelty
Open review: visible, citable, CV-worthy
Templates (START) + an open Handbook help doing it well
No APCs, relatively quick turnaround
Route 1
A different vision of publishing
Scholar-owned: public constitution, participatory governance, no commercial control, a large team.
Diamond OA — a commitment to openness and independence. Going against the open-access industry: ~$8.97B in APCs to six publishers (2019–2023). (Haustein et al., 2024)
A credible commitment: pledged to run at least to early 2028, then evaluated against pre-defined, public criteria.
Route 1 · take part
Submit, or review for R2.
That replication sitting in your drawer; a (good)student project; your next planned one.
Or sign up to review, open, visible, constructive.
Route 1 · practical aside
Want to replicate? Four lenses for a good target
1 · Replication value
How much does it matter whether this holds? RVCn ≈ citations/yr × 1/√n is a shortlist heuristic. (Isager et al., 2025)
2 · Personal motivation
Why does this study matter to you? What can you learn? Replicating can be a great way in.
3 · Feasibility
Materials, data, expertise: can you (do you want to) actually pull it off?
4 · Prior replications
Has it already been tested? Check the Atlas first.
Not every replication should be a standalone paper.
Many of us want to ask new questions — and a stand-alone replication can be a hard sell against career incentives and our own curiosity.
So there's a second route that, done right, produces replications anyway.
The reframe
Replicate and extend
Replication as a prospective design tool, not a retrospective audit.
First test whether a prior effect / method / paradigm / measure holds…
…then build on that base to probe a new boundary condition, mechanism, or outcome.
We often do this anyway. We just rarely report the first step as a replication. Worth changing, to make science more cumulative (and disciplined).
Why?
It embeds replication in "normal" research
It rides the incentive most researchers already have (novelty) — so the replication actually gets done …
… and reaches a normal journal as part of a novel paper.
One concrete way to deliver our broader ambition to mainstream replications.
Doing cumulative research right
Keep the replication interpretable
"If I change the population, the measure, and the context all at once,a null can't tell me whether the original was false or my extension changed the conditions... and my contribution to cumulative knowledge is unclear even if I succeed."
Keep the replication arm close enough to update confidence in the original; preregister the replication target.
Strive to reduce publication bias — purely "conceptual" replications, selectively published, can keep a zombie field alive (cf. social priming).
Haven't I heard that before?
Not an entirely new idea, but closer to motivations?
Builds on existing taxonomy: constructive replication and the Systematic Replications Framework.
But those still rely on researchers volunteering to do the "more boring" first steps.
Normalising replication as the foundation within a paper may be more realistic, it aligns with what people already want to do.
The flip side: sometimes the extension is just a vehicle to publish a replication you wanted for its own sake ... then maybe drop the extension and send it to R2?
(I'm writing this up for Social Psychology & Personality Compass, so tell me where it breaks.)
Pulling it together
Two routes, one goal
Route 1
Replication is the contribution → R2.
Route 2
Replication serves a new claim → normal journal, with the replication arm logged in FLoRA so it directly informs how we read the original.
Does a brand-new journal help my CV? New journals don't inherit prestige ... but R2 offers fit-for-purpose review, open visibility, indexing, no APCs; can show commitment to open science that some CV readers are looking for.
Doesn't a dedicated journal silo replications? A real risk; R2 isn't a substitute for journals taking responsibility; it's exactly why Route 2 matters too.
Will R2 publish weak replications to get volume? No. Design/power justification, preregistration where appropriate, transparency, methodological + open review.
Can a crowd-built FLoRA be trusted? Provenance tracked, validation status flagged, ongoing community validation ... hence the validation "game".